title: [Why is PET/CT essential in urooncology?].
abstract: The wide use of molecular positron emission tomography/computed tomography (PET/CT) imaging in the tumor diagnostics has been playing an important role recently. The clinical role of hybrid imaging (PET/CT, single photon ECT/CT (SPECT/CT)) is growing continuously due to the simultaneous imaging of anatomy and function. Regarding oncology the role of (18)F-fluorodeoxyglucose ((18)F-FDG) PET is proved in several clinical questions, including urooncology. Urologic cancers are associated with low or slightly significant uptake of FDG, due to their more benign behaviour. However, alternative PET tracers have been developed which show promising clinical results and hopefully, in the near future the combination of different tracers are awaited. Additionally, in the future the use of multiparametric measurements, multitracer techniques, and the multimodal PET/magnetic resonance imaging (PET/MRI) technology is going to have a crucial clinical role.
authors.affiliation: Országos Onkológiai Intézet, Budapest, Hungary. katalin.borbely@oncol.hu.
authors.forename: Katalin
authors.initials: K
authors.lastname: Borbély
authors.affiliation: Országos Onkológiai Intézet, Budapest, Hungary. katalin.borbely@oncol.hu.
authors.forename: Lajos
authors.initials: L
authors.lastname: Géczi
authors.affiliation: Országos Onkológiai Intézet, Budapest, Hungary. katalin.borbely@oncol.hu.
authors.forename: Miklós
authors.initials: M
authors.lastname: Kásler
mesh_terms: D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D008297:Male; D064847:Multimodal Imaging / Q000379:methods*; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000175:diagnosis; D049268:Positron-Emission Tomography / Q000379:methods; D011471:Prostatic Neoplasms / Q000175:diagnosis; D019275:Radiopharmaceuticals; D013736:Testicular Neoplasms / Q000175:diagnosis; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis; D014565:Urogenital Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000532:radiotherapy
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18